Selected reaction monitoring (SRM) analysis of epidermal growth factor receptor (EGFR) in formalin fixed tumor tissue

Clinical Proteomics

Volumn 9, Issue 1, 2012, Pages

  Hembrough, Todd ^a   Thyparambil, Sheeno ^a   Liao, Wei Li ^a   Darfler, Marlene M ^a   Abdo, Joseph ^a   Bengali, Kathleen M ^a   Taylor, Paul ^b   Tong, Jiefei ^b   Lara Guerra, Humberto ^c   Waddell, Thomas K ^c   Moran, Michael F ^b,d,e   Tsao, Ming Sound ^d,e   Krizman, David B ^a   Burrows, Jon ^a  

^a Onco Plex Diagnostics Inc   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C RECEPTOR;

ACCURACY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LUNG NON SMALL CELL CANCER; MASS SPECTROMETRY; MASS SPECTROMETRY BASED SELECTED REACTION MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION ASSAY; PROTEIN TARGETING; PYROCOCCUS FURIOSUS; QUANTITATIVE ASSAY; REPRODUCIBILITY; VALIDITY;

EID: 84885869771     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-9-5     Document Type: Article

References (40)

1. Yarden Y: The EGFR family and its ligands in human cancer. Signaling mechanisms and therapeutic opportunities. Eur J Cancer 2001, 37:3-8.
2. Schlessinger J: Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002, 110:669-672. (Pubitemid 35283957)
3. Pawson T: Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 2004, 116:191-203. (Pubitemid 38167312)
4. Vivanco I, Mellinghoff IK: Epidermal growth factor receptor inhibitors in oncology. Curr Opin Oncol 2010, 22:573-578.
5. Fruehauf J: EGFR function and detection in cancer therapy. J Exp Ther Oncol 2006, 5:231-246. (Pubitemid 43843833)
6. Mascaux C, Wynes MW, Kato Y, et al: EGFR Protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor - A novel antibody for immunohistochemistry or AQUA technology. Clin Cancer Res 2011, 17:7796-7807.
7. Pirker R, Pereira JR, von Pawel J, et al: EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: Analysis of data from the phase 3 FLEX study. Lancet Oncol 2012, 13:33-42.
8. Aebersold R, Mann M: Mass spectrometry-based proteomics. Nature 2003, 422:198-207. (Pubitemid 36362757)
9. Ong SE, Mann M: Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 2005, 1:252-262.
10. Addona TA, Abbatiello SE, Schilling B, et al: Multi-site assessment of the precision and reproducibility of selected reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009, 27:633-641.
11. Nilsson T, Mann M, Aebersold R, et al: Mass spectrometry in highthroughput proteomics: Ready for the big time. Nat Methods 2010, 7:681-685.
12. Rudnick PA, Clauser KR, Kilpatrick LE, et al: Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Mol Cell Proteomics 2010, 9:225-241.
13. Prieto DA, Hood BL, Darfler MM, et al: Liquid Tissue: proteomic profiling of formalin-fixed tissues. Biotechniques 2005, Jun(Suppl):32-35.
14. Hood BL, Darfler MM, Guiel TG, et al: Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics 2005, 4:1741-1753. (Pubitemid 41749267)
15. Patel V, Hood BL, Molinolo AA, et al: Proteomic analysis of laser-captured paraffin-embedded tissues: A molecular portrait of head and neck cancer progression. Clin Cancer Res 2008, 14:1002-1014. (Pubitemid 351302545)
16. Cheung W, Darfler MM, Alvarez H, et al: Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors. Pancreatology 2008, 8:608-616.
17. Bateman NW, Sun M, Bhargava R, et al: Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues. J Proteome Res 2011, 10:1323-1332.
18. Nishimura T, Nomura M, Tojo H, et al: Proteomic analysis of laser-microdissected paraffin-embedded tissues: (2) SRM assay for stage-related proteins upon nonmetastatic lung adenocarcinoma. Proteomics 2010, 73:1100-1110.
19. De Souza LV, Krakovska O, Darfler MM, et al: mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues. Proteomics 2010, 10:3108-3116.
20. Güzel C, Ursem NT, Dekker LJ, et al: Multiple reaction monitoring assay for preeclampsia related calcyclin peptides in formalin fixed paraffin embedded placenta. J. Proteome Res 2011, 10:3274-3282.
21. Wei Y, Tong J, Taylor P, et al: Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. J Proteome Res 2011, 10:161-174.
22. Lara-Guerra H, Waddell TK, Salvarrey MA, et al: Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer. J Clin Oncol 2009, 27:6229-6236.
23. Pegram MD, Lipton A, Hayes DF, et al: Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol 1998, 16:2659-2671. (Pubitemid 28363029)
24. Druker BJ, Talpaz M, Resta DJ, et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001, 344:1031-1037. (Pubitemid 32267972)
25. Cregger M, Berger AJ, Rimm DL: Immunohistochemistry and quantitative analysis of protein expression. Arch Pathol Lab Med 2006, 130:1026-1030. (Pubitemid 44061434)
26. Taylor CR: Standardization in immunohistochemistry: The role of antigen retrieval in molecular morphology. Biotech Histochem 2006, 81:3-12. (Pubitemid 43879085)
27. Walker RA: Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment. Histopathology 2006, 49:406-410. (Pubitemid 44401548)
28. Leong TY, Leong AS: How does antigen retrieval work? Adv Anat Pathol 2007, 14:129-131. (Pubitemid 46673287)
29. Anagnostou VK, Welsh AW, Giltnane JM, et al: Analytic variability in immunohistochemistry biomarker studies. Cancer Epidemiol Biomarkers Prev 2010, 19:982-991.
30. Daneshtalab N, Doré JJ, Smeda JS: Troubleshooting tissue specificity and antibody selection: Procedures in immunohistochemical studies. J Pharmacol Toxicol Methods 2010, 61:127-135.
31. Mason JT, O'Leary TJ: Effects of formaldehyde fixation on protein secondary structure: A calorimetric and infrared spectroscopic investigation. J Histochem Cytochem 1991, 39:225-229.
32. Rait VK, O'Leary TJ, Mason JT: Modeling formalin fixation and antigen retrieval with bovine pancreatic ribonuclease A: I-structural and functional alterations. Lab Invest 2004, 84:292-299. (Pubitemid 41656484)
33. Rait VK, Xu L, O'Leary TJ, Mason JT: Modeling formalin fixation and antigen retrieval with bovine pancreatic RNase A II. Interrelationship of cross-linking, immunoreactivity, and heat treatment. Lab Invest 2004, 84:300-306. (Pubitemid 41656485)
34. Fowler CB, Cunningham RE, O'Leary TJ, Mason JT: 'Tissue surrogates' as a model for archival formalin-fixed, paraffin-embedded tissues. Lab Invest 2007, 87:836-846. (Pubitemid 47077261)
35. Huang SK, Darfler MM, Nicholl MB, et al: LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS One 2009, 4:e4430.
36. Sprung RW Jr, Brock JW, Tanksley JP, et al: Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography tandem mass spectrometry shotgun proteomic analysis. Mol Cell Proteomics 2009, 8:1988-1998.
37. Bell LN, Saxena R, Mattar SG, et al: Utility of formalin-fixed, paraffinembedded liver biopsy specimens for global proteomic analysis in nonalcoholic steatohepatitis. Proteomics Clin Appl 2011, 5:397-404.
38. Nirmalan NJ, Hughes C, Peng J, et al: Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations. J Proteome Res 2011, 10:896-906.
39. Ikeda K, Monden T, Kanoh T, et al: Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem 1998, 46:397-403. (Pubitemid 28117390)
40. Becker KF, Schott C, Hipp S, Metzger V, et al: Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol. 2007, 211:370-378. (Pubitemid 46172713)